Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fananapazir

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Molecular and Cellular Cardiology|September 1, 2000
Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathyT M Olson, T P Doan, N Y Kishimoto, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1985
Comparison of vitreous carbon and elgiloy transvenous ventricular pacing leadsA O Molajo, R J Bowes, L Fananapazir, et al.
Circulation|June 1, 1988
Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden deathL Fananapazir, D L Packer, L D German, et al.
Circulation|May 1, 1991
Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathyR O Cannon, V Dilsizian, P T O'Gara, et al.
Circulation|February 1, 1992
Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathyN D Epstein, L Fananapazir, H J Lin, et al.
Circulation|November 1, 1989
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patientsL Fananapazir, C M Tracy, M B Leon, et al.
Nature Genetics|May 1, 1996
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleK Poetter, H Jiang, S Hassanzadeh, et al.
Circulation|January 4, 2001
Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosisA Karibe, L S Tobacman, J Strand, et al.
Journal of the American College of Cardiology|November 1, 1990
Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteriesR O Cannon, A A Quyyumi, W H Schenke, et al.
Circulation|March 1, 1992
Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathyR O Cannon, V Dilsizian, P T O'Gara, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Molecular and Cellular Cardiology|September 1, 2000
Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathyT M Olson, T P Doan, N Y Kishimoto, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1985
Comparison of vitreous carbon and elgiloy transvenous ventricular pacing leadsA O Molajo, R J Bowes, L Fananapazir, et al.
Circulation|June 1, 1988
Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden deathL Fananapazir, D L Packer, L D German, et al.
Circulation|May 1, 1991
Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathyR O Cannon, V Dilsizian, P T O'Gara, et al.
Circulation|February 1, 1992
Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathyN D Epstein, L Fananapazir, H J Lin, et al.
Circulation|November 1, 1989
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patientsL Fananapazir, C M Tracy, M B Leon, et al.
Nature Genetics|May 1, 1996
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleK Poetter, H Jiang, S Hassanzadeh, et al.
Circulation|January 4, 2001
Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosisA Karibe, L S Tobacman, J Strand, et al.
Journal of the American College of Cardiology|November 1, 1990
Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteriesR O Cannon, A A Quyyumi, W H Schenke, et al.
Circulation|March 1, 1992
Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathyR O Cannon, V Dilsizian, P T O'Gara, et al.
Pageof 7